Quotables
"Man will not fly for 50 years."
Wilbur Wright ; 1901
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7772407 | C-glycoside derivatives and salts thereof The present invention provides C-glycoside derivatives and salts thereof, wherein B ring is bonded to A ring via —X— and A ring is directly bonded to the glucose residue, and it is usable as a Na+-glucose cotransporter inhibitor, especially for a ther... | 08/10/2010 |
| 7393846 | Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, the... | 07/01/2008 |
| 7354949 | Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia The present invention provides a therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia comprising, as an active ingredient, a tricyclic compound represented by formula (I): [wherein ... | 04/08/2008 |
| 7332615 | Hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents The present invention discloses hydrophilic derivatives of 4,8-dihydrobenzodithiophene-4,8-diones, which are active as anticancer agents, along with pharmaceutical formulations containing the same. ... | 02/19/2008 |
| 7276532 | Remedies for vesical hyperactivity The present invention provides a therapeutic agent for overactive bladder comprising, as an active ingredient, a tricyclic compound represented by formula (I): [wherein R1 represents a hydrogen atom, s... | 10/02/2007 |
| 7238725 | Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes. ... | 07/03/2007 |
| 7223789 | Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, the... | 05/29/2007 |
| 7175961 | Photopatternable molecular circuitry Bistable molecules are provided with at least one photosensitive functional group. As thus constituted, the bistable molecules are photopatternable, thereby allowing fabrication of micrometer-scale and nanometer-scale circuits in discrete areas without relying on a ... | 02/13/2007 |
| 7101905 | Pharmaceutically active compounds and methods of use New fused thiophene compounds are provided and methods of using those compounds for a variety of therapeutic indications. Compounds of the invention are particularly useful for treatment of neuropathic pain. ... | 09/05/2006 |
| 6818260 | Thienothiophene derivatives The invention relates to new thienothiophene derivatives, their use as semiconductors or charge transport materials, in optical, electrooptical or electronic devices like for example organic field effect transistors (FET or OFET) for thin film transistor liquid crys... | 11/16/2004 |
| 6693136 | Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors Compounds of formula (I) ##STR1## are novel P2X3 and P2X2 /P2X3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.... | 02/17/2004 |
| 6605632 | Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them The invention concerns compounds of formula (I): R--A--R' wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R1, R2, R3, v and R4 are as defined in the desc... | 08/12/2003 |
| 6602901 | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) The present invention relates to compounds of formula (I) ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, Ar, X, Q, A, Y and Z are as defined in the specification. These ... | 08/05/2003 |
| 6509499 | Nitromethylthiobenzene derivatives as inhibitors of aldose reductase The invention concerns novel compound of general formula (1) in which: P, T1, T2, X and n are as defined in claim 1, their tautomeric forms, and their additive salts with pharmaceutically acceptable bases. The invention also concerns... | 01/21/2003 |
| 6495701 | Method for manufacturing tricyclic amino alcohol derivatives The present invention is directed to processes for the preparation of a compound useful for treating diabetes, obesity, hyperlipidemia and the like, which compound is represented by the formula (1): ##STR1## wherein R1 represents a lower alkyl ... | 12/17/2002 |
| 6429312 | N-aminoalkyldibenzothiopencarboxamide receptor subtype specific ligands Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4 are the same or different and represent hydrogen, C1 -C6 ... | 08/06/2002 |
| 6337346 | Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents Compounds useful as cytotoxic agents are selected from the group consisting of compounds of Formula I and compounds of Formula II: ##STR1## wherein: R1, R2, R3 and R4 are each independently selected from the gro... | 01/08/2002 |
| 6300339 | Compounds, their preparation and use The present invention relates to compounds of formula (I) ##STR1## wherein A, B, Q, T, X, Y, Z, R5, R6, R7, R8, Ar, k, m, n and p are as defined in the specification. These compounds are useful in treating or pr... | 10/09/2001 |
| 6251936 | Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia This invention provides compounds of Formula I having the structure ##STR1## E is S, SO, SO2, O, or NR1c ; X is hydrogen, halogen, alkyl of 1-6 carbon atoms, alkenyl of 2-7 carbon atoms, CN, aryl, aralkyl of 6-12 carbon atoms, hydroxyalky... | 06/26/2001 |
| 6187809 | Tricyclic compounds and drug compositions containing the same Compounds having a ଲ-3 adrenaline receptor agonist and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc., represented by a general formula (I) and salts thereof, and a process for producing these, and thei... | 02/13/2001 |
| 6174913 | Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents Compounds useful as cytotoxic agents are selected from the group consisting of compounds of Formula I and compounds of Formula II: ##STR1## wherein: R1, R2, R3 and R4 are each independently selected from the gro... | 01/16/2001 |
| 6172099 | Tricyclic compounds having saturated rings and medicinal compositions containing the same Compounds represented by general formula (I) or their salts, having 댣 -adrenoceptor agonism and being efficacious when employed in drugs for treating and preventing diabetes, obesity, hyperlipemia, etc. wherein R represents hydrogen or m... | 01/09/2001 |
| 6172104 | Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof Methods of treating Pneumocystis carinii pneumonia comprise administering a therapeutically effective amount of a dicationic dibenzofuran compound described by Formula (I). Methods of treating Pneumocystis carinii pneumonia also comprise administering a t... | 01/09/2001 |
| 6080338 | Water soluble photochromic compounds, compositions and optical elements comprising the compounds Described are novel water soluble photochromic naphthopyran and benzopyran compounds having an alkylaminoalkylamino group on the pyran portion or on the pyran portion and the naphtho- or benzo-portion thereof. These compounds may be represented by one of ... | 06/27/2000 |
| 6040459 | N-aminoalkyldibenzothiophenecarboxamides; new dopamine receptor subtype specific ligands Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4 are the same or different and represent hydrogen, C1 -C | 03/21/2000 |
| 6037361 | Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases Fluorinated butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase)... | 03/14/2000 |
| 5990104 | Polycyclic alcaloid-derivatives as NMDA-receptor antagonists Polycyclic alkaloids of formula (I), wherein R1 is H, C1-6 alkyl, or C6-12 aryl optionally substituted with polar groups; R2 and R3 are independently H, OH, C1-6 alkyl, --C(NH)--NH2, ... | 11/23/1999 |
| 5917057 | N-hydroxy-dibenzb,e!oxepinalkylamines, n-hydroxy-dibenzb,e!oxepinalkanoic acid amides and related heterocyclic analogues This invention relates to N-hydroxy-dibenzb,e!oxepinalkylamines, N-hydroxy-dibenzb,e!oxepinalkanoic acid amides and related heterocyclic analogues of the formula ##STR1## where X together with the carbon atoms to which it is attached forms a ... | 06/29/1999 |
| 5879592 | Water soluble photochromic compounds, compositions and optical elements comprising the compounds Described are novel water soluble photochromic naphthopyran and benzopyran compounds having an alkylaminoalkylamino group on the naphtho- or benzo-portions and/or pyran portions thereof. These compounds may be represented by one of the following graphic f... | 03/09/1999 |
| 5840980 | Diamine compounds and electrophotographic photoreceptor A diamine compound of the following formula (1): ##STR1## wherein R1 is a hydrogen atom, a lower alkyl group or a lower alkoxy group, each of A1, A2 and A3 which are independent of one another, is a substit... | 11/24/1998 |
| 5824662 | Treatment of global and focal ischemia using naaladase inhibitors The present invention includes compositions and methods of treatment for glutamate abnormalities and associated nervous tissue insult in a animal by inhibition of NAALADase enzyme. Compositions include glutamate-derived hydroxyphosphinyl derivative compou... | 10/20/1998 |
| 5763609 | Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4 are the same or different and represent hydrogen, C1 -C | 06/09/1998 |
| 5726208 | Heterocyclic tertiary amines New compounds of formula: ##STR1## wherein: --A--D--E, X, n, Y and Z are as defined in the description, in racemic form and in the form of optical isomers, and their addition salts with pharmaceutically acceptable acids. Those compounds may be used as med... | 03/10/1998 |
| 5726325 | Tricyclic compounds The present invention relates to tricyclic compounds represented by general formula (I) which are useful as therapeutic agents for urinary incontinence: ##STR1## wherein R1 represents hydrogen and the like; --X1 --X2 ... | 03/10/1998 |
| 5578252 | Photochromic substituted naphthopyran compounds Described are novel reversible photochromic 3H-naphtho[2,1-b]pyran compounds, examples of which are substituted with an oxy-bearing substituent at the number 8 carbon atom and with either an alkyl group at the number 7 carbon atom or with a carbonyl beari... | 11/26/1996 |
| 5569771 | (Haloalkyl) dibenzooniumsulfonate and its production methods; and a haloalkylating agent and haloalkylating methods (Haloalkyl)dibenzooniumsulfonate represented by the following general formula (I): ##STR1## By using this compound as the haloalkylating agent, haloalkylated organic compounds being non-water-soluble as the objective product can very easily be s... | 10/29/1996 |
| 5294522 | Photochromic compound A novel photochromic compound as a photoreactive material making use of photochromism is provided, which compound is expressed by the following formula (1) or (2)): ##STR1## wherein R is alkyl, alkoxy, perfluoroalkyl or cyano; X1, X2 | 03/15/1994 |
| 5292894 | Preparation of benzo[b]thiophenes A process for the preparation of benzo[b]thiophenes of the general formula I ##STR1## in which R1, R2, R3, R4 independently denote hydrogen, C1 -C4 alkyl, C1 -C4 ... | 03/08/1994 |
| 5276053 | Polycyclic amines useful as cerebrovascular agents A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of cerebrovascular disorders are disclosed.... | 01/04/1994 |
| 5130058 | Photochromic compound, process for production thereof, use thereof and composition containing said photochromic compound A photochromic compound represented by the following general formula [I] ##STR1## wherein ##STR2## represents a divalent aromatic hydrocarbon group or a divalent heterocyclic group each of which may have a substituent, R1 represents ... | 07/14/1992 |
